melatonin has been researched along with oxidopamine in 41 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 13 (31.71) | 18.2507 |
| 2000's | 15 (36.59) | 29.6817 |
| 2010's | 10 (24.39) | 24.3611 |
| 2020's | 3 (7.32) | 2.80 |
| Authors | Studies |
|---|---|
| Burton, S; Daya, S; Potgieter, B | 1 |
| Bartmann, M; Hagel, G; Schaeffel, F; Zrenner, E | 1 |
| Niles, LP; Tenn, CC | 1 |
| Weekley, LB | 1 |
| Oxenkrug, GF; Requintina, PJ; Reuss, S; Riemann, R | 1 |
| Hoffmann, M; Schaeffel, F | 1 |
| Antolin, I; Esteban, MM; Mayo, JC; Rodriguez, C; Sainz, RM; Uria, H | 1 |
| Baik, HH; Cho, YH; Jin, BK; Joo, WS; Kim, YS; Park, CW | 1 |
| Antolín, I; Estéban, MM; Mayo, JC; Sainz, RM; Uría, H | 1 |
| Jin, BK; Joo, WS; Kim, YS; Maeng, SH; Park, CW | 1 |
| Antolín, I; Mayo, JC; Rodriguez, C; Sainz, RM | 1 |
| Dragunow, M; MacGibbon, G; Walton, M; Woodgate, A | 1 |
| Armstrong, SM; Willis, GL | 1 |
| Dabbeni-Sala, F; Franceschini, D; Giusti, P; Skaper, SD | 1 |
| Han, ES; Jang, YY; Kwon, OS; Lee, CS; Park, JW; Youn, YC | 1 |
| Aguiar, LM; Sousa, FC; Vasconcelos, SM; Viana, GS | 1 |
| Bayarri, MJ; Madrid, JA; Rol de Lama, MA; Sánchez-Vázquez, FJ | 1 |
| Chetsawang, B; Ebadi, M; Govitrapong, P | 1 |
| Robertson, AD; Willis, GL | 1 |
| Daya, S; Maharaj, H; Mokokong, R; Scheepers, M; Sukhdev Maharaj, D | 1 |
| McMillan, CR; Niles, LP; Sharma, R; Tenn, CC | 1 |
| Maĭs'kyĭ, VO; Oleshko, MM; Sahach, VF; Talanov, SO | 1 |
| Ahmed, R; Krishana, B; Sagar, RK; Singh, S | 1 |
| McMillan, CR; Niles, LP; Sharma, R | 1 |
| Alarma-Estrany, P; Crooke, A; Peral, A; Pintor, J | 1 |
| Bartell, PA; McIvor, W; Menaker, M; Miranda-Anaya, M | 1 |
| Sahach, VF; Talanov, SA | 1 |
| Borah, A; Mohanakumar, KP | 1 |
| Lin, L; Liu, TT; Meng, T; Zheng, ZH | 1 |
| Lin, L; Liu, T; Meng, T; Zheng, Z | 1 |
| Du, Y; Lin, L; Lin, X; Shen, J; Yuan, S; Zheng, Z | 1 |
| Agar, A; Aslan, M; Dilmac, S; Gemici, B; Kaya, Y; Ogut, E; Ozkan, A; Ozsoy, O; Tanriover, G; Yildirim, FB | 1 |
| Galisteo, J; Herraiz, T | 1 |
| Lin, L; Liu, T; Meng, T; Yuan, S; Zheng, Z | 1 |
| Agar, A; Aslan, M; Kaya, Y; Ogut, E; Ozsoy, O; Parlak, H; Tanriover, G; Yildirim, FB | 1 |
| Butenko, GM; Kopjak, BS; Kyzminova, IA; Labunets, IF; Podjachenko, EV; Rodnichenko, AE; Sagach, VF; Talanov, SA; Utko, NA; Vasilyev, RG | 1 |
| Guo, L; Li, L; Li, Y; Wang, SM; Wang, Y; Zhao, YX; Zhu, J | 1 |
| Ivanets, EV; Menchinskaya, ES; Pislyagin, EA; Smetanina, OF; Trinh, PTH; Yurchenko, AN; Yurchenko, EA | 1 |
| Atanasov, AG; Kalfin, R; Lazarova, M; Saso, L; Stefanova, M; Tancheva, L; Uzunova, D | 1 |
| Alavinejad, N; Apetz, N; Drzezga, A; Endepols, H; Neumaier, B; Vus, S; Zischler, J; Zlatopolskiy, BD | 1 |
| Boracı, H; Gergin, S; Kirazlı, Ö; Şehirli, ÜS; Yananlı, HR; Yıldız, SD | 1 |
41 other study(ies) available for melatonin and oxidopamine
| Article | Year |
|---|---|
Melatonin modulates apomorphine-induced rotational behaviour.
Topics: Animals; Apomorphine; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Huntington Disease; Hydroxydopamines; Male; Melatonin; Motor Activity; Oxidopamine; Parkinson Disease, Secondary; Quinolinic Acid; Quinolinic Acids; Rats; Rats, Inbred Strains | 1991 |
Studies on the role of the retinal dopamine/melatonin system in experimental refractive errors in chickens.
Topics: 5,7-Dihydroxytryptamine; Animals; Chickens; Circadian Rhythm; Dopamine; Electroretinography; Male; Melatonin; Myopia; Oxidopamine; Receptors, Dopamine D1; Refractive Errors; Reserpine; Retina; Sensory Deprivation; Serotonin Antagonists; Sulpiride | 1995 |
Central-type benzodiazepine receptors mediate the antidopaminergic effect of clonazepam and melatonin in 6-hydroxydopamine lesioned rats: involvement of a GABAergic mechanism.
Topics: Animals; Apomorphine; Behavior, Animal; Bicuculline; Clonazepam; Corpus Striatum; Dopamine Agonists; Flumazenil; Flunitrazepam; gamma-Aminobutyric Acid; Isoquinolines; Male; Melatonin; Oxidopamine; Rats; Rats, Sprague-Dawley; Receptors, GABA-A | 1995 |
Effects of melatonin on pulmonary and coronary vessels are exerted through perivascular nerves.
Topics: Animals; Coronary Vessels; Female; In Vitro Techniques; Melatonin; Muscle Relaxation; Muscle, Smooth, Vascular; Oxidopamine; Potassium Chloride; Pulmonary Artery; Substance P; Swine; Vasoactive Intestinal Peptide | 1993 |
Clorgyline effect on pineal melatonin biosynthesis in adrenalectomized rats pretreated with 6-hydroxydopamine.
Topics: Adrenalectomy; Animals; Clorgyline; Male; Melatonin; Oxidopamine; Pineal Gland; Rats; Rats, Sprague-Dawley; Serotonin; Sympathectomy, Chemical | 1994 |
Melatonin and deprivation myopia in chickens.
Topics: 5,7-Dihydroxytryptamine; Animals; Behavior, Animal; Chickens; Circadian Rhythm; Electroretinography; Male; Melatonin; Myopia; Oxidopamine; Refraction, Ocular; Retina; Sensory Deprivation; Serotonin Agents; Sympatholytics; Vision, Monocular; Visual Pathways | 1996 |
Melatonin prevents apoptosis induced by 6-hydroxydopamine in neuronal cells: implications for Parkinson's disease.
Topics: Animals; Apoptosis; Cell Survival; Cells, Cultured; DNA Fragmentation; Melatonin; Neurons; Oxidopamine; Parkinson Disease; PC12 Cells; Rats; Sympatholytics | 1998 |
Melatonin protects 6-OHDA-induced neuronal death of nigrostriatal dopaminergic system.
Topics: Animals; Antioxidants; Cell Death; Corpus Striatum; Dopamine; Immunohistochemistry; Male; Melatonin; Microinjections; Neurons; Neuroprotective Agents; Oxidopamine; Rats; Rats, Sprague-Dawley; Substantia Nigra; Sympatholytics; Tyrosine 3-Monooxygenase | 1998 |
Inhibition of cell proliferation: a mechanism likely to mediate the prevention of neuronal cell death by melatonin.
Topics: Animals; Antineoplastic Agents; Antioxidants; Blotting, Northern; Cell Count; Cell Cycle; Cell Differentiation; Cell Division; Cell Survival; DNA; DNA Fragmentation; Histones; Male; Melatonin; Oxidopamine; PC12 Cells; Rats; RNA, Messenger | 1998 |
Melatonin increases striatal dopaminergic function in 6-OHDA-lesioned rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antioxidants; Corpus Striatum; Dopamine; Male; Malondialdehyde; Melatonin; Oxidopamine; Rats; Tyrosine 3-Monooxygenase | 1998 |
Ultrastructural confirmation of neuronal protection by melatonin against the neurotoxin 6-hydroxydopamine cell damage.
Topics: Animals; Apoptosis; Dose-Response Relationship, Drug; Melatonin; Microscopy, Electron; Neurons; Neuroprotective Agents; Neurotoxins; Oxidopamine; PC12 Cells; Rats | 1999 |
The toxicity of 6-hydroxydopamine on PC12 and P19 cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Aurintricarboxylic Acid; Biological Transport; Bisbenzimidazole; Carrier Proteins; Cell Membrane; Desipramine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fluorescent Dyes; Free Radical Scavengers; In Situ Nick-End Labeling; Melatonin; Membrane Glycoproteins; Membrane Transport Proteins; Necrosis; Nerve Tissue Proteins; Neurons; NG-Nitroarginine Methyl Ester; Oxidopamine; Parkinson Disease, Secondary; PC12 Cells; Rats; Sympatholytics; Tretinoin; Tritium | 1999 |
A therapeutic role for melatonin antagonism in experimental models of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Biological Availability; Body Weight; Circadian Rhythm; Disease Models, Animal; Dyskinesia, Drug-Induced; Free Radical Scavengers; Male; Melatonin; Motor Activity; Oxidopamine; Parkinson Disease; Photoperiod; Phototherapy; Pineal Gland; Rats; Rats, Sprague-Dawley | 1999 |
Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for mitochondrial complex I activity.
Topics: Adenosine Triphosphatases; Animals; Apomorphine; Behavior, Animal; Disease Models, Animal; Electron Transport Complex IV; Electrophoresis, Polyacrylamide Gel; Male; Melatonin; Mitochondria; Motor Activity; NAD; Neuroprotective Agents; Oxidative Phosphorylation; Oxidopamine; Parkinson Disease; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Substantia Nigra | 2001 |
Protective effect of serotonin on 6-hydroxydopamine- and dopamine-induced oxidative damage of brain mitochondria and synaptosomes and PC12 cells.
Topics: Animals; Brain; Calcium; Dopamine; Free Radical Scavengers; Hydrogen Peroxide; Intracellular Membranes; Male; Malondialdehyde; Melatonin; Mitochondria; Neuroprotective Agents; Oxidation-Reduction; Oxidative Stress; Oxidopamine; PC12 Cells; Permeability; Rats; Rats, Sprague-Dawley; Serotonin; Sulfhydryl Compounds; Superoxides; Synaptosomes | 2002 |
Melatonin reverses neurochemical alterations induced by 6-OHDA in rat striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Free Radical Scavengers; Homovanillic Acid; Hydroxyindoleacetic Acid; Injections, Intraperitoneal; Male; Melatonin; Microinjections; Oxidopamine; Rats; Rats, Wistar; Serotonin; Sympatholytics | 2002 |
Both pineal and lateral eyes are needed to sustain daily circulating melatonin rhythms in sea bass.
Topics: Adrenergic Agents; Animals; Bass; Circadian Rhythm; Eye Enucleation; Melatonin; Ocular Physiological Phenomena; Optic Nerve Injuries; Oxidopamine; Photoreceptor Cells, Vertebrate; Pineal Gland; Retina | 2003 |
The neuroprotective effect of melatonin against the induction of c-Jun phosphorylation by 6-hydroxydopamine on SK-N-SH cells.
Topics: Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; JNK Mitogen-Activated Protein Kinases; Melatonin; Neuroprotective Agents; Oxidopamine; Phosphorylation | 2004 |
Recovery of experimental Parkinson's disease with the melatonin analogues ML-23 and S-20928 in a chronic, bilateral 6-OHDA model: a new mechanism involving antagonism of the melatonin receptor.
Topics: 5-Methoxytryptamine; Animals; Male; Melatonin; Naphthalenes; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Receptors, Melatonin; Recovery of Function | 2004 |
l-DOPA administration enhances 6-hydroxydopamine generation.
Topics: Animals; Antioxidants; Antiparkinson Agents; Ascorbic Acid; Corpus Striatum; Drug Interactions; Edetic Acid; Hydroxylation; Iron; Levodopa; Lipid Peroxidation; Male; Melatonin; Oxidopamine; Rats; Rats, Wistar | 2005 |
Physiological neuroprotection by melatonin in a 6-hydroxydopamine model of Parkinson's disease.
Topics: Animals; Apomorphine; Brain-Derived Neurotrophic Factor; Densitometry; Dopamine Agonists; Functional Laterality; Glial Cell Line-Derived Neurotrophic Factor; Immunohistochemistry; Male; Melatonin; Neostriatum; Neuroprotective Agents; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Receptor, Melatonin, MT1; Receptors, Melatonin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stereotyped Behavior; Sympatholytics; Tyrosine 3-Monooxygenase | 2006 |
[Inhibitors of mitochondrial permeability transition pore prevent apoptosis of dopaminergic neurons in the mesencephalon].
Topics: Animals; Apoptosis; Chromans; Dopamine; Male; Melatonin; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Neurons; Oxidopamine; Rats; Rats, Inbred WKY; Substantia Nigra; Ventral Tegmental Area | 2006 |
Neuroprotection of the nigrostriatal dopaminergic neurons by melatonin in hemiparkinsonium rat.
Topics: Animals; Dopamine; Female; Melatonin; Neurons; Neuroprotective Agents; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Visual Cortex | 2006 |
Neural stem cell transplantation and melatonin treatment in a 6-hydroxydopamine model of Parkinson's disease.
Topics: Animals; Behavior, Animal; Cell Line; Disease Models, Animal; Male; Melatonin; Neurons; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Stem Cell Transplantation; Tyrosine 3-Monooxygenase | 2007 |
Requirement of intact sympathetic transmission for the ocular hypotensive effects of melatonin and 5-MCA-NAT.
Topics: Adrenergic Uptake Inhibitors; Animals; Central Nervous System Depressants; Dose-Response Relationship, Drug; Drug Interactions; Male; Melatonin; Ocular Hypertension; Oxidopamine; Rabbits; Reserpine; Sympathectomy, Chemical; Sympathetic Nervous System; Sympatholytics; Tryptamines; Vesicular Monoamine Transport Proteins | 2007 |
Interactions between dopamine and melatonin organize circadian rhythmicity in the retina of the green iguana.
Topics: Animals; Cell Culture Techniques; Chromatography, High Pressure Liquid; Circadian Rhythm; Dopamine; Dopamine Antagonists; Iguanas; Immunohistochemistry; Melatonin; Oxidopamine; Quinpirole; Retina; Salicylamides | 2007 |
[Antioxidants prevent experimental hemiparkinsonism in rats].
Topics: Animals; Antioxidants; Behavior, Animal; Chromans; Disease Models, Animal; Dopamine; Male; Melatonin; Neurons; Oxidative Stress; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Inbred WKY; Substantia Nigra; Ubiquinone | 2008 |
Melatonin inhibits 6-hydroxydopamine production in the brain to protect against experimental parkinsonism in rodents.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Ascorbic Acid; Brain; Central Nervous System Depressants; Chromatography, High Pressure Liquid; Dopamine; Dopamine Agents; Ferrous Compounds; Levodopa; Male; Melatonin; Mice; Mice, Inbred BALB C; Oxidopamine; Parkinsonian Disorders | 2009 |
Contralateral retinal dopamine decrease and melatonin increase in progression of hemiparkinsonium rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Chromatography, High Pressure Liquid; Disease Progression; Dopamine; Homovanillic Acid; Melatonin; Oxidopamine; Parkinson Disease; Rats; Retina; Spectrometry, Fluorescence | 2012 |
Increased melatonin may play dual roles in the striata of a 6-hydroxydopamine model of Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Chromatography, High Pressure Liquid; Corpus Striatum; Data Interpretation, Statistical; Disease Models, Animal; Dopamine; Homovanillic Acid; Male; Melatonin; Microdialysis; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley | 2013 |
Serum melatonin is an alternative index of Parkinson's disease severity.
Topics: Aged; Aged, 80 and over; Animals; Apomorphine; Biomarkers; Dopamine Agonists; Female; Humans; Male; Melatonin; Middle Aged; Motor Activity; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Time Factors | 2014 |
Mechanism of the beneficial effect of melatonin in experimental Parkinson's disease.
Topics: Animals; Antioxidants; Dopaminergic Neurons; Male; Melatonin; Motor Activity; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Wistar; Substantia Nigra | 2014 |
Hydroxyl radical reactions and the radical scavenging activity of β-carboline alkaloids.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Alkaloids; Antioxidants; Ascorbic Acid; Carbolines; Chromatography, High Pressure Liquid; Deoxyguanosine; Hydrogen Peroxide; Hydroxyl Radical; Melatonin; Oxidative Stress; Oxidopamine | 2015 |
Effects of endogenous melatonin on glutamate and GABA rhythms in the striatum of unilateral 6-hydroxydopamine-lesioned rats.
Topics: Animals; Chromatography, Liquid; Circadian Rhythm; Corpus Striatum; Dopamine; gamma-Aminobutyric Acid; Glutamic Acid; Male; Melatonin; Oxidopamine; Rats; Rats, Sprague-Dawley | 2015 |
Melatonin is protective against 6-hydroxydopamine-induced oxidative stress in a hemiparkinsonian rat model.
Topics: Animals; Catalase; Drug Evaluation, Preclinical; Free Radical Scavengers; Glutathione Peroxidase; Lipid Peroxidation; Male; Medial Forebrain Bundle; Melatonin; Motor Activity; Neuroprotective Agents; Oxidopamine; Parkinson Disease, Secondary; Rats, Wistar; Substantia Nigra; Superoxide Dismutase; Tyrosine 3-Monooxygenase | 2015 |
[THYMIC HORMONES, ANTIOXIDANT ENZYMES AND NEUROGENESIS OF BULBUS OLFACTORIUS IN RATS WITH PARKINSONISM: THE EFFECT OF MELATONIN].
Topics: Animals; Antioxidants; Apomorphine; Ataxia; Catalase; Cell Count; Cell Differentiation; Dopamine Agonists; Gene Expression; Glutathione Peroxidase; Male; Melatonin; Nestin; Neural Stem Cells; Neuroprotective Agents; Olfactory Bulb; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Wistar; Superoxide Dismutase; Thymic Factor, Circulating; Thymus Gland | 2015 |
Effects of Melatonin Levels on Neurotoxicity of the Medial Prefrontal Cortex in a Rat Model of Parkinson's Disease.
Topics: Animals; Male; Melatonin; Oxidopamine; Parkinson Disease; Pars Compacta; Prefrontal Cortex; Rats; Rats, Wistar; Tyrosine 3-Monooxygenase; Ventral Tegmental Area | 2017 |
Neuroprotective Activity of Some Marine Fungal Metabolites in the 6-Hydroxydopamin- and Paraquat-Induced Parkinson's Disease Models.
Topics: Alkaloids; Animals; Antioxidants; Antiparkinson Agents; Aquatic Organisms; Aspergillus; Biological Products; Cell Line, Tumor; Cell Survival; Melatonin; Mice; Neuroprotective Agents; Oxidopamine; Paraquat; Parkinsonian Disorders; Penicillium; Polyketides; Reactive Oxygen Species | 2018 |
Beneficial Effect of Melatonin on Motor and Memory Disturbances in 6-OHDA-Lesioned Rats.
Topics: Animals; Antiparkinson Agents; Brain; Male; Melatonin; Memory; Movement; Neurotransmitter Agents; Oxidopamine; Parkinson Disease; Rats; Rats, Wistar | 2021 |
Imaging of cerebral tryptophan metabolism using 7-[
Topics: Animals; Disease Models, Animal; Fluorine Radioisotopes; Hippocampus; Kynurenine; Male; Melatonin; Oxidopamine; Parkinson Disease; Pineal Gland; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Long-Evans; Serotonin; Tryptophan | 2022 |
The effects of regular swimming exercise and melatonin on the neurons localized in the striatum of hemiparkinsonian rats.
Topics: Animals; Male; Melatonin; Neurons; Oxidopamine; Parkinson Disease; Physical Conditioning, Animal; Rats; Rats, Wistar; Substantia Nigra; Swimming; Tyrosine 3-Monooxygenase | 2023 |